-
Why The Crypto Market Excitement About An IPO Wave Faded
17 Apr 2025 15:12 GMT
Eli Lilly (LLY) stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds over the course of 40 weeks.
The news solidifies Lilly's lead in developing an oral treatment for obesity. It …
-
Safety worries spur Pfizer to drop another obesity pill
14 Apr 2025 23:59 GMT
… In a statement, Chris Boshoff, Pfizer’s top scientist, said the … development, the company said.
Pfizer still has other candidates in … among Wall Street analysts that Pfizer might turn to deals … raise $275 million in an initial public offering in January.
-
Pfizer Halts Development Of Oral Weight-Loss Pill After Liver Injury Case In Patient
14 Apr 2025 13:18 GMT
… the medication was stopped.
Pfizer had been testing multiple … however, developed liver injury.
Pfizer said that “after a … of investigational treatments," Pfizer’s chief scientific officer, … trends, stock updates, tax, IPO, banking finance, real estate, …
-
FTSE surges to longest winning streak on record
02 May 2025 17:58 GMT
… plans for a multibillion-pound initial public offering (IPO). Ministers have been pushing for … after the announcement of a Pfizer vaccine offering a path out …
-
Global IPO market overview
29 Mar 2025 00:17 GMT
… at 1,340 IPOs.
View full image: Global IPO deal value and … in select IPO hubs.
View full image: Top-10 IPOs, globally, … of large, private equity-backed IPOs, including pharmaceuticals business Galderma landing … £2.57 billion that enabled Pfizer to sell a 7.7 …
-
India: Kotak buys $122m stake in IPO-bound Tirupati as Affirma Capital exits
26 Mar 2025 15:45 GMT
… , Dr. Reddy’s, Torrent, Macleods, Pfizer, Lupin, and Dabur, and manufactures … ’s expansion plans and its IPO preparation.
Affirma manages over $4 … recently, KAAML backed India’s IPO-bound Neuberg Diagnostics with Rs …
-
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
21 Mar 2025 14:43 GMT
… Pharmaceuticals (ALNY) will take on Pfizer's (PFE) Vyndaqel and … enough for all three players.
Pfizer's Vyndaqel earned $5 … To Buy And Watch: Top IPOs, Big And Small Caps, Growth …
-
Updates on health agency nominees; New data from Pfizer, Beam; MASH startup weighs IPO; and more
15 Mar 2025 11:01 GMT
-
Aardvark Therapeutics Gets $94 Million IPO to Power Obesity Treatments
13 Feb 2025 18:15 GMT
… speculation with a $94 million initial public offering, putting itself on the … initially filed plans for its IPO in late January without … currently dominating the market.
The IPO comes after an $85 … 7 billion valuation in an IPO. Pfizer and Biohaven are both …
-
Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax
28 Apr 2025 11:00 GMT
… such as Takeda, AstraZeneca, Merck, Pfizer and Innovent; and research and … Company for its Hong Kong initial public offering dated October 16, 2019, and …